Sumeet Bagadia's Stock Recommendations: Buy Sun Pharma, HDFC Life, Jindal Steel

As the Indian stock market faces ongoing volatility, Sumeet Bagadia, Executive Director at Choice Broking, has identified three stocks that investors should consider buying on Monday, July 28, 2025. The recommendations come in light of the Nifty 50 index's recent performance, having decisively broken below the critical 50-day exponential moving average (DEMA) support level of 24,900.

### Current Market Context The Indian stock market has been under pressure, with the Nifty 50 index experiencing a decline for four consecutive weeks. The index ended nearly 400 points lower than its weekly high of 24,837, reflecting a 0.53% decrease for the week. This trend has raised concerns among investors, particularly as trading volumes decreased by 4% in the National Stock Exchange (NSE) cash market compared to the previous day.

In this context, Bagadia's recommendations highlight stocks that exhibit relative strength amid a broadly negative market. Notably, Cipla, SBI Life, and Apollo Hospitals have shown resilience, emerging as top performers despite the prevailing market conditions. Conversely, financial heavyweights such as Bajaj Finance and Shriram Finance suffered significant losses during the same period.

### Stock Recommendations Bagadia's analysis focuses on three stocks that stand out based on their technical performance:

1. **Sun Pharmaceutical Industries (Sun Pharma)** - **Current Price**: ₹1,699 - **Target Price**: ₹1,850 - **Stop Loss**: ₹1,620 - Sun Pharma has demonstrated an overall uptrend, recently consolidating within a defined range after reaching a record high. The stock's price action indicates a potential reversal, supported by robust trading volumes and accumulation near demand zones. A breakout above ₹1,730 could signal a continuation of the upward trend.

2. **HDFC Life Insurance Company** - **Current Price**: ₹762.35 - **Target Price**: ₹825 - **Stop Loss**: ₹730 - HDFC Life's stock remains in a broader uptrend, having recently retraced towards its demand zones. Technical indicators suggest a potential reversal, with a breakout above ₹775 likely to trigger further upward momentum.

3. **Jindal Steel and Power** - **Current Price**: ₹1,000.15 - **Target Price**: ₹1,090 - **Stop Loss**: ₹955 - Jindal Steel's stock has recently completed a bullish Inverted Head & Shoulders pattern, indicating a possible trend reversal. The breakout above the neckline resistance at ₹980, coupled with rising volumes, reinforces the bullish outlook for this stock.

### Conclusion Investors are advised to take a stock-specific approach amid the current market uncertainties. While the broader market remains under pressure, these three stocks—Sun Pharma, HDFC Life, and Jindal Steel—present attractive opportunities based on their technical setups and market resilience. As always, investors should conduct thorough research and consider consulting certified financial experts before making investment decisions.

This analysis underscores the importance of technical indicators in navigating the complexities of the stock market and highlights the potential for strategic investments even in challenging market conditions.